diallyl disulfide has been researched along with Leucocythaemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Guangqun, C; Hui, L; Hui, T; Jie, H; Lan, Y; Ran, L; Su, Q; Yiling, J | 1 |
| He, J; Ji, X; Jia, Y; Lei, Y; Ling, H; Liu, F; Su, Q; Tan, H; Xia, H; Yi, L; Zeng, X | 1 |
| Bandyopadhyay, SS; Dasgupta, P | 1 |
| Chen, DL; Feng, ZQ; Li, J; Luo, N; Shi, QQ; Zhao, LC | 1 |
| He, J; Li, Q; Qin, J; Su, Q; Tan, H; Tang, Y; Wang, J; Yang, Y; Yi, L | 1 |
| Ai, X; He, J; Hu, H; Ji, X; Jiang, H; Ling, H; Liu, F; Su, Q; Tan, H; Wu, Y; Yi, L; Zeng, X | 1 |
| Kim, HR; Kim, JS; Kwon, KB; Park, BH; Park, JW; Rho, HW; Ryu, DG; Yang, JY; Yoo, SJ | 1 |
7 other study(ies) available for diallyl disulfide and Leucocythaemia
| Article | Year |
|---|---|
Diallyl disulfide downregulating RhoGDI2 induces differentiation and inhibit invasion via the Rac1/Pak1/LIMK1 pathway in human leukemia HL-60 cells.
Topics: Allyl Compounds; Cell Differentiation; Disulfides; HL-60 Cells; Humans; Leukemia; Lim Kinases; Neoplasm Invasiveness; p21-Activated Kinases; rac1 GTP-Binding Protein; rho Guanine Nucleotide Dissociation Inhibitor beta; RNA, Messenger | 2023 |
Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1/ROCK1/LIMK1 pathway in leukemia cells.
Topics: Allyl Compounds; Antineoplastic Agents; Cell Differentiation; Cell Movement; Cofilin 1; Disulfides; Down-Regulation; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia; Lim Kinases; Phosphorylation; rac1 GTP-Binding Protein; rho-Associated Kinases; Signal Transduction | 2020 |
Role of di-allyl disulfide, a garlic component in NF-κB mediated transient G2-M phase arrest and apoptosis in human leukemic cell-lines.
Topics: Allyl Compounds; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Disulfides; G2 Phase Cell Cycle Checkpoints; Garlic; Gene Expression Regulation, Leukemic; Humans; Leukemia; M Phase Cell Cycle Checkpoints; Mitochondria; NF-kappa B; Nitriles; Sulfones | 2013 |
Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways.
Topics: Allyl Compounds; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disulfides; ErbB Receptors; HL-60 Cells; Humans; K562 Cells; Leukemia; MAP Kinase Signaling System; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Signal Transduction; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2015 |
Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment.
Topics: Allyl Compounds; Disulfides; Gene Expression; HL-60 Cells; Humans; Immunohistochemistry; Intracellular Space; Leukemia; Mitochondria; Protein Deglycase DJ-1; Protein Transport | 2016 |
Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide.
Topics: Allyl Compounds; Animals; CD11b Antigen; Cell Cycle Checkpoints; Cell Differentiation; Cell Movement; Cell Proliferation; Disulfides; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia; Mice; Proteome; Xenograft Model Antitumor Assays | 2017 |
Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells.
Topics: Allyl Compounds; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cell Survival; Disulfides; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Reactive Oxygen Species | 2002 |